Immunity following use of Australian tick fever vaccine: A review of the evidence

Australian Veterinary Journal

Volumn 79, Issue 12, 2001, Pages 832-839

  Bock, R E ^a   De Vos, A J ^a  

^a Tick Fever Research Centre   (Australia)

Author keywords

Anaplasma centrale; Anaplasma marginale; Babesia bigemina; Babesia bovis; Live cattle exports; Tick fever; Vaccination

Indexed keywords

ACARI; ANAPLASMA CENTRALE; ANAPLASMA MARGINALE; ANIMALIA; BABESIA BIGEMINA; BABESIA BOVIS; BOS TAURUS;

PROTOZOAL VACCINE; PROTOZOON ANTIBODY;

ACTIVE IMMUNIZATION; ANAPLASMA; ANAPLASMOSIS; ANIMAL; ANIMAL DISEASE; AUSTRALIA; BABESIA; BABESIA BOVIS; BABESIOSIS; BLOOD; CATTLE; CATTLE DISEASE; IMMUNOLOGY; REVIEW; TICK BORNE DISEASE; VACCINATION;

ANAPLASMA; ANAPLASMOSIS; ANIMALS; ANTIBODIES, PROTOZOAN; AUSTRALIA; BABESIA; BABESIA BOVIS; BABESIOSIS; CATTLE; CATTLE DISEASES; IMMUNITY, ACTIVE; PROTOZOAN VACCINES; TICK-BORNE DISEASES; VACCINATION;

EID: 0035748876     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2001.tb10931.x     Document Type: Article

References (77)

1. Chudleigh P. Tick-borne disease control in cattle. In: Economic Assessment Series. Australian Centre for International Agricultural Research, Canberra, 1991;5:1-24.
2. McLeod R, Kristjanson P. Economic impact of ticks and tick-borne diseases to livestock in Africa, Asia and Australia. International Livestock Research Institute, Nairobi, 1999.
3. de Castro JJ. Sustainable tick and tickborne disease control in livestock improvement in developing countries. Vet Parasitol 1997;71:77-97.
4. Callow LL, Dalgliesh RJ, de Vos AJ. Development of effective living vaccines against bovine babesiosis - the longest field trial? Int J Parasitol 1997;27:747-67.
5. Anonymous. Ticks and Tick-borne Disease Control: A Practical Field Manual. Vol II Tick-borne Disease Control. FAO, Rome, 1984.
6. de Vos AJ, Pipano E, Musisi F, Jorgensen WK. Protozoal and Rickettsial Vaccines. In: Mowat G, Rweyemamu M, editors. Vaccine Manual - The production and quality control of veterinary vaccines for use in developing countries. FAO, Rome, 1997:75-89.
7. de Vos AJ, Jorgensen WK. Bovine babesiosis. In: Manual of Standards for Diagnostic Tests and Vaccines. Office International des Epizootic, Paris, 1996:333-338.
8. de Vos AJ, Dalgliesh RJ, Callow LL. Babesia. In: Soulsby EJL, editor. Immune responses in parasitic infections: immunology, immunopathology and immunoprophylaxis. CRC Press, Boca Raton, 1987;111.
9. Mahoney DF. Immune responses to hemoprotozoa II. Babesia spp. In: Soulsby EJL, editor. Immunity to animal parasites. Academic Press, New York, 1972:301-341.
10. Brown WC, Palmer GH. Designing blood-stage vaccines against Babesia bovis and B. bigemina. Parasitol Today 1999;15:275-281.
11. Emmerson FR, Knott SG, Callow LL. Vaccination with Babesia argentina in 5 beef herds in south-eastern Queensland. Aust Vet J 1976;52:451-454.
12. Dalgliesh RJ. Babesiosis. In: Warren SK, editor. Immunology and molecular biology of parasite infections. Blackwell, Oxford, 1993:352-383.
13. Dalrymple B. Diversity and selection in Babesia bovis and their impact on vaccine use. Parasitol Today 1992;8:21-23.
14. Lew AE, Bock RE, Croft JM et al. Genotypic diversity in field isolates of Babesia bovis from cattle with babesiosis after vaccination. Aust Vet J 1997;75:575-578.
15. Callow LL. A note on homologous strain immunity in Babesia argentina infections. Aust Vet J 1968;44:268-269.
16. Callow LL, Dalgliesh RJ. The development of effective, safe vaccination against babesiosis and anaplasmosis in Australia. In: Johnston LAY, Cooper MG, editors. Ticks and Tick borne Diseases. Proceedings of a Symposium held at the 56th Annual Conference of the Australian Veterinary Association, Townsville, 1980:4-8.
17. de Vos AJ, Bessenger R, Fourie CG. Virulence and heterologous strain immunity of South African and Australian Babesia bovis strains with reduced pathogenicity. Onderstepoort J Vet Res 1982;49:133-136.
18. Lawrence JA, Malika J, Whiteland AP, Kafuwa P. Efficacy of an Australian Babesia bovis vaccine strain in Malawi. Vet Rec 1993;132:295-296.
19. Brizuela CM, Ortellado CA, Sanabria E, Torres O, Ortigosa D. The safety and efficacy of Australian tick-borne disease vaccine strains in cattle in Paraguay. Vet Parasitol 1998;76:27-41.
20. Callow LL, Quiroga QC, McCosker PJ. Serological comparison of Australian and South American strains of Babesia argentina and Anap/asma marginale. Int J Parasitol 1976;6:307-310.
21. Callow LL. Tick-borne livestock diseases and their vectors. 3. Australian methods of vaccination against anaplasmosis and babesiosis. World Anim Rev 1976;18:9-15.
22. Callow LL, Mellors LT, McGregor W. Reduction in virulence of Babesia bovis due to rapid passage in splenectomized cattle. Int J Parasitol 1979;9:333-338.
23. Timms P, Stewart NP, De Vos AJ. Study of virulence and vector transmission of Babesia bovis by use of cloned parasite lines. Infect Immun 1990;58:2171-2176.
24. Bock RE, de Vos AJ, Kingston TG, Shiels IA, Dalgliesh RJ. Investigations of breakdowns in protection provided by living Babesia bovis vaccine. Vet Parasitol 1992;43:45-56.
25. Bock RE, de Vos AJ, Lew A, Kingston TG, Fraser IR. Studies on failure of T strain live Babesia bovis vaccine. Aust Vet J 1995;72:296-300.
26. de Vos AJ. Immunogenicity and pathogenicity of three South African strains of Babesia bovis in Bos indicus cattle. Onderstepoort J Vet Res 1978;45:119-124.
27. Timms P. Development of babesial vaccines. Trans R Soc Trop Med Hyg 1989;83:73-79.
28. Gill AC, Cowman AF, Stewart NP, Kemp DJ, Timms P. Babesia bovis: molecular and biological characteristics of cloned parasite lines. Exp Parasitol 1987;63:180-188.
29. Lew AE, Dalrymple BP, Jeston PJ, Bock RE. PCR methods for the discrimination of Babesia bovis isolates. Vet Parasitol 1997;71:223-237.
30. Mahoney DF, Wright IG, Goodger BV. Immunity in cattle to Babesia bovis after single infections with parasites of various origin. Aust Vet J 1979;55:10-12.
31. Mahoney DF, Wright IG, Mirre GB. Bovine babesiasis: the persistence of immunity to Babesia argentina and B. bigemina in calves (Bos taurus) after naturally acquired infection. Ann Trop Med Parasitol 1973;67:197-203.
32. Tjornehoj KT, Lawrence JA, Whiteland AP, Kafuwa PT. Field observations on the duration of immunity in cattle after vaccination against Anaplasma and Babesia species. Onderstepoort J Vet Res 1996;63:1-5.
33. Meehan JF. Field proof for the tick fever vaccine. Old Agric J 1969;95:768-771.
34. Tizzard IR. Veterinary Immunology - An introduction. 5th edn. Saunders, Philadelphia, 1996.
35. Bock RE, de Vos AJ, Kingston TG, McLellan DJ. Effect of breed of cattle on innate resistance to infection with Babesia bovis, B bigemina and Anaplasma marginale [Published erratum appears in Aust Vet J 1997;75:449]. Aust Vet J 1997;75:337-340.
36. Bock RE, Kingston TG, de Vos AJ. Effect of breed of cattle on transmission rate and innate resistance to infection with Babesia bovis and B bigemina transmitted by Boophilus microplus. Aust Vet J 1999;77:461-464.
37. Wright IG, Goodger BV, Leatch G et al. Protection of Babesia bigemina-immune animals against subsequent challenge with virulent Babesia bovis. Infect Immun 1987;55:364-368.
38. Callow LL. Sterile immunity, coinfectious immunity and strain differences in Babesia bigemina infections. Parasitology 1967;57:455-465.
39. Bock R, de Vos A, Rayner A et al. Assessment of the risk of tick fever mortalities in north-western Queensland beef industry. In: Challenging the boundaries, Proceedings of section of Annual Conference, Australian Association of Cattle Veterinarians. Australian Veterinary Association, Brisbane, 1997:175-182.
40. Callow LL. Some aspects of the epidemiology and control of bovine babesiosis in Australia. J S Afr Vet Assoc 1979;50:353-356.
41. Callow LL. Piroplasms. In: Animal Health in Australia, Protozoal and rickettsial diseases. Australian Bureau of Animal Health, AGPS, Canberra, 1984;5:121-160.
42. Dalgliesh RJ, Callow LL, Mellors LT, McGregor W. Development of a highly infective Babesia bigemina vaccine of reduced virulence. Aust Vet J 1981;57:8-11.
43. Jorgensen WK, De Vos AJ, Dalgliesh RJ. Comparison of immunogenicity and virulence between Babesia bigemina parasites from continuous culture and from a splenectomised calf. Aust Vet J 1989;66:371-372.
44. de Vos AJ, Combrink MP, Bessenger R. Babesia bigemina vaccine: comparison of the efficacy and safety of Australian and South African strains under experimental conditions in South Africa. Onderstepoort J Vet Res 1982;49:155-158.
45. de Waal D. Vaccination against babesiosis. Acta Parasit Turcica 1996;20:487-499.
46. Turton J, Katsande T. Bovine babesiosis and anaplasmosis in Zimbabwe. In: Proceedings of the 2nd Tick-Host-Pathogen Interface Conference, Berg-en-Dal, 1995:46.
47. Katsande TC, Turton JA. Progress on the production of frozen Anaplasma and Babesia whole blood vaccines at the Central Veterinary Laboratory in Harare. In: Proceedings of the Zimbabwe Veterinary Congress, Harare, Zimbabwe, 1995.
48. Tjornehoj K, Lawrence JA, Kafuwa PT, Whiteland AP, Chimera BA. Immunisation of smallholder dairy cattle against anaplasmosis and babesiosis in Malawi. Trop Anim Health Prod 1997;29:77-82.
49. -G, Standfast NF, de Vos AJ. Effect of cattle breed on innate resistance to inoculations of Babesia bigemina. Aust Vet J 1999;77:465-466.
50. Palmer GH, Rurangirwa FR, Kocan KM, Brown WC. Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol Today 1999;15:281-286.
51. Palmer G. Anaplasma vaccines. In: Wright I, editor. Veterinary Protozoan and Hemoparasite Vaccines. CRC Press, Boca Raton, 1989:1-29.
52. Eriks IS, Stiller D, Goff WL et al. Molecular and biological characterization of a newly isolated Anaplasma marginale strain. J Vet Diagn Invest 1994;6:435-441.
53. Tebele N, Palmer GH. Crossprotective immunity between the Florida and a Zimbabwe stock of Anaplasma marginale. Trop Anim Health Prod 1991;23:197-202.
54. Wilson AJ, Parker R, Trueman KF. Experimental immunization of calves against Anaplasma marginale infection: observations on the use of living A centrale and A marginale. Vet Parasitol 1980;7:305-311.
55. Angus B. The history of the cattle tick Boophilus microplus in Australia and achievements in its control. International Journal of Parasitology 1996;26:1341-1355.
56. Rogers RJ, Shiels IA. Epidemiology and control of anaplasmosis in Australia. J S Afr Vet Assoc 1979;50:363-366.
57. Potgieter FT. Epizootiology and control of anaplasmosis in South Africa. J S Afr Vet Assoc 1979;50:367-72.
58. Anziani OS, Tarabla HD, Ford CA, Galleto C. Vaccination with Anaplasma centrale: response after an experimental challenge with Anaplasma marginale. Trop Anim Health Prod 1987;19:83-87.
59. Nari A, Solari M, Cardozo H. Hemovacuna para el control de Babesia spp. y Anaplasma marginale en el Uruguay. Veterinaria (Montevideo, Uruguay) 1979;15:137-148.
60. Pipano E, Krigel Y, Frank M, Markovics A, Mayer E. Frozen Anaplasma centrale vaccine against anaplasmosis in cattle. Br Vet J 1986;142:553-556.
61. Turton JA, Katsande TC, Matingo MB et al. Observations on the use of Anaplasma centrale for immunization of cattle against anaplasmosis in Zimbabwe. Onderstepoort J Vet Res 1998;65:81-86.
62. Kuttler KL. A study of the immunological relationship of Anaplasma marginale and Anaplasma centrale. Res Vet Sci 1967;8:467-471.
63. Potgieter FT, Van Rensburg L. Infectivity virulence and immunogenicity of Anaplasma centrale live blood vaccine. Onderstepoort J Vet Res 1983;50:29-31.
64. Gale KR, Leatch G, DeVos AJ, Jorgensen WK. Anaplasma marginale: effect of challenge of cattle with varying doses of infected erythrocytes. Int J Parasitol 1996;26:1417-1420.
65. Payne RC, Osorio O, Ybanez A. Tick-borne diseases of cattle in Paraguay. II. Immunisation against anaplasmosis and babesiosis. Trop Anim Health Prod 1990;22:101-108.
66. Adams JH, Shiels IA, de Vos AJ. Heterologous antibody responses of calves to Anaplasma centrale and A. marginale. Vet Parasitol 1989;31:7-12.
67. Shkap V, Pipano E, McGuire TC, Palmer GH. Identification of immunodominant polypeptides common between Anaplasma centrale and Anaplasma marginale. Vet Immunol Immunopathol 1991;29:31-40.
68. Krigel Y, Pipano E, Shkap V. Duration of carrier state following vaccination with live Anaplasma centrale. Trop Anim Health Prod 1992:24:209-210.
69. Molloy JB, Bock RE, Templeton JM et al. Monoclonal antibodies differentiate between the Australian vaccine strain of A. centrale and A. marginale: Development of a fluorescent antibody test specific for A. centrale and an ELISA for the serological identification of vaccinated cattle. Int J Parasitol 2001;31:179-186.
70. Wright IG, Leatch G. Bovine anaplasmosis. In: Manual of standards for diagnostic tests and vaccines. Office International des Épizooties, Paris, 1996:295-304.
71. Roby TO, Amerault TE, Mazzola V, Rose JE, Ilemobade A. Immunity in bovine anaplasmosis after elimination of Anaplasma marginale infections with imidocarb. Am J Vet Res 1974;35:993-995.
72. Wilson AJ. Observations on the pathogenesis of anaplasmosis in cattle with particular reference to nutrition, breed and age. J S Afr Vet Assoc 1979;50:293-295.
73. Kuttler KL, Zaugg JL, Johnson LW. Serologic and clinical responses of premunized, vaccinated, and previously infected cattle to challenge exposure by two different Anaplasma marginale isolates. Am J Vet Res 1984;45:2223-2226.
74. Bock RE, Kingston TG, de Vos AJ. Effect of breed of cattle on innate resistance to infection with Anaplasma marginale transmitted by Boophilus microplus. Aust Vet J1999;77:748-751.
75. Court RA, Sitte K, Opdebeeck JP, East IJ. Mapping the T cell epitopes of the Babesia bovis antigen 12D3: implications for vaccine design. Parasite Immunol 1998;20:1-8.
76. Dalgliesh RJ, Jorgensen WK, de Vos AJ. Australian frozen vaccines for the control of babesiosis and anaplasmosis in cattle - a review. Trop Anim Health Prod 1990;22:44-52.
77. Callow LL, Pepper PM. Measurement of and correlations between fever, changes in the packed cell volume and parasitaemia in the evaluation of the susceptibility of cattle to infection with Babesia argentina. Aust Vet J 1974;50:1-5.